None
Quote | Virtus LifeSci Biotech Clinical Trials (NYSE:BBC)
Last: | $24.8772 |
---|---|
Change Percent: | -0.85% |
Open: | $25.59 |
Close: | $24.8772 |
High: | $25.59 |
Low: | $24.57 |
Volume: | 2,095 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Virtus LifeSci Biotech Clinical Trials (NYSE:BBC)
2024-04-16 10:30:00 ET Summary The rise in rates last week pushed the 10-year to its highest level since the peak at 5% in October of last year. Gold has been setting new highs, trading above $2400 at one point on Friday before succumbing to some profit taking. Year-to-date, t...
2024-04-15 09:50:00 ET Summary Powerful investment themes, such as AI, can capture the market’s collective imagination. Taken to an extreme, however, they can also trigger distortions across and within the markets. In our 2Q 2024 Equity Outlook, we examine key historic dist...
Message Board Posts | Virtus LifeSci Biotech Clinical Trials (NYSE:BBC)
Subject | By | Source | When |
---|---|---|---|
Biotechs' Second-Half Battle | stockguard | investorshub | 07/22/2019 7:16:46 PM |
Big pharmas billion-dollar bets | stockguard | investorshub | 06/14/2019 8:21:04 PM |
How high will the Healthcare/Biotech sector go in 2019? | stockguard | investorshub | 04/05/2019 5:29:49 PM |
Biotech Is Worth The Hype, But Do You | stockguard | investorshub | 03/02/2019 7:01:31 PM |
IBB: This Is Only The Beginning | stockguard | investorshub | 02/19/2019 7:31:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Virtus LifeSci Biotech Clinical Trials Company Name:
BBC Stock Symbol:
NYSE Market:
2024-04-09 22:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
In a recent incident at Donald Trump’s Mar-a-Lago resort, U.S. House Republican Marjorie Taylor Greene had a heated confrontation with Britis...
A restaurant owner was left with hefty losses following a lengthy trademark dispute with Elon Musk's Tesla. What Happened: According to a ...